Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension

被引：0
|
作者：
Abreu, M. T.
Danese, S.
Sandborn, W. J.
Miao, Y.
Tikhonov, I.
Zhang, H.
Panacciones, R.
Hisamatsu, T.
Scherl, E. J.
Leong, R. W.
Rowbotham, D. S.
Arasaradnam, R. P.
Afif, W.
Peyrin-Biroulet, L.
Sands, B. E.
Marano, C.
机构：
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP83
引用
收藏
页码：S113 / S114
页数：4
相关论文
共 50 条
  • [1] Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension
    Abreu, Maria T.
    Rowbotham, David S.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Tikhonov, Ilia
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert W.
    Arasaradnam, Ramesh P.
    Afif, Waqqas
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Marano, Colleen
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (08): : 1222 - 1234
  • [2] Efficacy of Ustekinumab for Ulcerative Colitis in Patients Through 3 Years: UNIFI Long-term Extension
    Abreu, Maria T.
    Rowbotham, David S.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen
    Leong, Rupert
    Arasaradnam, Ramesh
    Afif, Waqqas
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Marano, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S315 - S315
  • [3] Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results From the UNIFI Long-Term Extension
    Sands, Bruce E.
    Abreu, Maria T.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert W.
    Rowbotham, David S.
    Arasaradnam, Ramesh P.
    Peyrin-Biroulet, Laurent
    Afif, Waqqas
    Marano, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S525 - S526
  • [4] Efficacy of ustekinumab for ulcerative colitis through 2 years: Results of the UNIFI maintenance study and long-term extension
    Panaccione, R.
    Sandborn, W. J.
    Sands, B. E.
    Marano, C.
    O'Brien, C. D.
    Zhang, H.
    Johanns, J.
    Zhou, Y.
    Peyrin-Biroulet, L.
    Hisamatsu, T.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S049 - S049
  • [5] EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 2 YEARS: RESULTS OF THE UNIFI MAINTENANCE STUDY AND LONG-TERM EXTENSION
    Sandborn, William J.
    Sands, Bruce E.
    Panaccione, Remo
    Marano, Colleen W.
    O'Brien, Christopher D.
    Zhang, Hongyan
    Johanns, Jewel
    Zhou, Yiying
    Peyrin-Biroulet, Laurent
    Hisamatsu, Tadakazu
    Danese, Silvio
    GASTROENTEROLOGY, 2020, 158 (06) : S1186 - S1186
  • [6] Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-Term Maintenance Study
    Afif, Waqqas
    Arasaradnam, Ramesh P.
    Abreu, Maria T.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert W.
    Rowbotham, David S.
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Marano, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (05): : 910 - 921
  • [7] Corticosteroid-sparing effects of ustekinumab therapy for Ulcerative Colitis through 3 years: UNIFI long-term extension
    Scherl, E. J.
    Rowbotham, D. S.
    Danese, S.
    Sandborn, W. J.
    Miao, Y.
    Zhang, H.
    Abreu, M. T.
    Panaccione, R.
    Afif, W.
    Hisamatsu, T.
    Leong, R. W.
    Arasaradnam, R. P.
    Sands, B. E.
    Marano, C.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S117 - S118
  • [8] Efficacy of ustekinumab for Ulcerative Colitis through 4 years: Final clinical and endoscopy outcomes from the UNIFI long-term extension
    Danese, S.
    Afif, W.
    Abreu, M.
    Sandborn, W.
    Miao, Y.
    Zhang, H.
    Panaccione, R.
    Hisamatsu, T.
    Scherl, E.
    Leong, R.
    Rowbotham, D.
    Arasaradnam, R.
    Peyrin-Biroulet, L.
    Sands, B.
    Marano, C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I19 - I20
  • [9] Efficacy of ustekinumab for ulcerative colitis through 4 years: Final clinical and endoscopy outcomes from the UNIFI long-term extension
    Danese, S.
    Afif, W.
    Abreu, M. T.
    Sandborn, W. J.
    Miao, Y.
    Zhang, H.
    Panaccione, R.
    Hisamatsu, T.
    Scherl, E. J.
    Leong, R.
    Rowbotham, D. S.
    Arasaradnam, R. P.
    Peyrin-Biroulet, L.
    Sands, B. E.
    Marano, C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 117 - 118
  • [10] EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 4 YEARS: FINAL CLINICAL AND ENDOSCOPY OUTCOMES FROM THE UNIFI LONG-TERM EXTENSION
    Peyrin-Biroulet, Laurent
    Afif, Waqqas
    Abreu, Maria T.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert
    Rowbotham, David S.
    Arasaradnam, Ramesh P.
    Sands, Bruce E.
    Marano, Colleen W.
    GASTROENTEROLOGY, 2023, 164 (06) : S1094 - S1094
12345